Search for: "Pfizer Inc." Results 181 - 200 of 1,510
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Apr 2018, 7:15 am by Ilya Somin
It shows how a group of lower-middle class New London, Connecticut homeowners found themselves steamrolled by a plan to take their land in order to facilitate a development project backed by powerful political forces, including Connecticut Governor John Rowland, the New London Development Corporation (the private organization that planned and conducted the takings on behalf of the City of New London), and Pfizer, Inc., a major pharmaceutical firm that hoped to benefit from the… [read post]
27 Mar 2018, 4:00 am by Michael Erdle
Pfizer Canada Inc. 2017 FC 826, the Federal Court said that the funding agreement is privileged and refused to order disclosure of the complete unredacted agreement to the defendant. [read post]
1 Mar 2018, 2:35 pm by Law Offices of Jeffrey S. Glassman
Several hundred testosterone drug injury lawsuits against drug makers Endo Pharmaceuticals Inc., GlaxoSmithKline LLC and Auxilium (an Endo unit) are on the verge of settlement. [read post]
1 Mar 2018, 2:35 pm by Law Offices of Jeffrey S. Glassman
Several hundred testosterone drug injury lawsuits against drug makers Endo Pharmaceuticals Inc., GlaxoSmithKline LLC and Auxilium (an Endo unit) are on the verge of settlement. [read post]
2 Feb 2018, 4:00 am by Michael Erdle
Pfizer Canada Inc. 2017 FC 826, the plaintiff and funder (Bentham IMF Canada) requested court approval of the funding agreement. [read post]
According to the Wall Street Journal, Pfizer Inc released a public statement on Saturday, January 6, 2018, announcing the end of R & D for new drugs for treatment of Alzheimer's Disease and Parkinson's Disease. [read post]
The plaintiffs in related cases originally filed their complaints in California state court alleging Lipitor, a prescription drug developed and manufactured by the defendant Pfizer, Inc. [read post]
1 Dec 2017, 11:35 am by Nate Nead
China’s Sanpower Group Co., Ltd. acquired Dendreon Pharmaceuticals Inc for $0.8 billion, and Sumitomo Dainippon Pharma Co., Ltd. acquired Tolero Pharmaceuticals Inc. for $0.8 billion to assist Sumitomo to refresh its pipeline.[28] In Q4 2017, a few M&A transactions have occurred in the pharma deal market. [read post]
17 Nov 2017, 3:00 am by John Jenkins
It fought the reelection of directors at companies such as Charter Communications Inc., Pfizer Inc. and PayPal Holdings, Inc., according to filings and a spokesman for the money manager. [read post]
12 Nov 2017, 11:00 pm by Kevin LaCroix
A recurring issue in securities cases involves the question of when plaintiffs may rely on the presumption of reliance under the fraud on the market doctrine. [read post]